プロキドニーに関するコメント

$プロキドニー(PROK.US)$ sank more than 15% Thursday as the biotech snapped a five-session winning streak that saw its price rise some 130% in just days.
PROK fell 15.5% to close at $2.40, ending a run-up that began last Thursday, April 11, despite no apparent news.
Shares gained 132.4% between the stock's $1.45 close on April 10 and its $3.37 peak this past Wednesday.
ProKidney, which is trying t...

$プロキドニー(PROK.US)$ rose more than 30% Tuesday as the biotech firm rallied for the fourth straight session – a run-up that's seen the stock rise nearly 90% in less than a week.
PROK gained 30.1% to close at $2.72, up 87.6% from last Wednesday's close at $1.45.
ProKidney has been soaring despite no news announcements, although the stock's rally began the day after $バーテックス・ファーマシューティカルズ(VRTX.US)$ unveiled plans to buy biotech $アルパイン・イミューン・サイエンシズ(ALPN.US)$ for $4.9 ...

$プロキドニー(PROK.US)$ come on 🐌 poke

$プロキドニー(PROK.US)$ 👁 hmm

$プロキドニー(PROK.US)$ ProKidney Corp Files For Mixed Shelf Offering Of $500M
Benzinga· 2 mins ago

$プロキドニー(PROK.US)$ Love how a share repurchase can cause such a nice rise!

Shares of $プロキドニー(PROK.US)$ are in the green today, despite recent sales from special purpose acquisition company (SPAC) sponsor Chamath Palihapitiya. Back in July of 2022, ProKidney agreed to merge with Social Capital Suvretta Holdings Corp III in a business combination valued at $2.64 billion. Since then, shares of PROK stock have plummeted by about 70%. Since the beginning of the year, PROK has fallen by about 59%.
Meanwhile, Palihapitiya rec...